Your browser doesn't support javascript.
loading
Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.
Tajiri, Kazuto; Tsukada, Kenichiro; Tokimitsu, Yoshiharu; Motofuji, Yuchi; Kawai, Kengo; Muraishi, Nozomu; Murayama, Aiko; Hayashi, Yuka; Shimizu, Yukihiro; Yasuda, Ichiro.
Afiliación
  • Tajiri K; Third Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Tsukada K; Department of Gastroenterology, Kouseiren Takaoka Hospital, Takaoka, Japan.
  • Tokimitsu Y; Department of Gastroenterology, Toyama Red Cross Hospital, Toyama, Japan.
  • Motofuji Y; Department of Gastroenterology, Shinseikai Toyama Hospital, Imizu, Japan.
  • Kawai K; Department of Gastroenterology, Nanto Municipal Hospital, Nanto, Japan.
  • Muraishi N; Third Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Murayama A; Third Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Hayashi Y; Third Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Shimizu Y; Department of Gastroenterology, Nanto Municipal Hospital, Nanto, Japan.
  • Yasuda I; Third Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
Oncology ; 102(2): 131-140, 2024.
Article en En | MEDLINE | ID: mdl-37666216
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Anticuerpos Monoclonales Humanizados / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Oncology Año: 2024 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Anticuerpos Monoclonales Humanizados / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Oncology Año: 2024 Tipo del documento: Article País de afiliación: Japón